DOD Biotech PCLBKK:DOD 76 OCF Margin % is -63.50% as of Mar. 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, DOD Biotech PCL ranks worse than 79.59% on this metric.
The historical rank and industry rank for DOD Biotech PCL's OCF Margin % or its related term are showing as below:
BKK:DOD'
s OCF Margin % Range Over the Past 10 Years
Min: -24.33 Med: 12.01 Max: 42.64
Current: -1.67
During the past 12 years, the highest OCF Margin % of DOD Biotech PCL was 42.64%. The lowest was -24.33%. And the median was 12.01%.
BKK:DOD's OCF Margin % is ranked worse than 79.59% of 1955
companies
in the Consumer Packaged Goods industry
Industry Median: 6.49
vs BKK:DOD: -1.67
DOD Biotech PCL OCF Margin % Related Terms
DOD Biotech PCL OCF Margin % Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, DOD Biotech PCL's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DOD Biotech PCL OCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's OCF Margin % distribution charts can be found below:
* The bar in red indicates where DOD Biotech PCL's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOD Biotech PCL (BKK:DOD) has a OCF Margin % of -63.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on DOD Biotech PCL and its competitors. According to the industry distribution chart, DOD Biotech PCL ranks #1556 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 79.6%.
Is DOD Biotech PCL's OCF Margin % too high?
DOD Biotech PCL's current OCF Margin % is -63.50%. Based on the distribution chart, DOD Biotech PCL ranks #1556 out of 1955 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's OCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, DOD Biotech PCL ranks #1556 out of 1955 companies for OCF Margin %. This places DOD Biotech PCL in the lower half of its industry. The industry median OCF Margin % is 6.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Consumer Packaged Goods company?
The median OCF Margin % among Consumer Packaged Goods companies is 6.49, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on DOD Biotech PCL and its competitors. For the Consumer Packaged Goods industry, the median OCF Margin % is 6.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DOD Biotech PCL's current OCF Margin % is -63.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.50 — trading 10.2% below its estimated fair value. The current OCF Margin % is -63.50%. DOD Biotech PCL's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current OCF Margin % is -63.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿1.50 is trading 10.2% below its estimated GF Value™ of ฿1.67.
GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.
Key valuation signals for BKK:DOD:
OCF Margin %: -63.50%
GF Value™: ฿1.67 vs. price of ฿1.50 (10.2% below fair value)
No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score
Get the complete analysis for BKK:DOD
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD has been successfully added to your 
